Does brain inflammation mediate pathological outcomes in epilepsy?
about
Epilepsy priorities in Europe: A report of the ILAE-IBE Epilepsy Advocacy Europe Task ForceEvaluating an etiologically relevant platform for therapy development for temporal lobe epilepsy: effects of carbamazepine and valproic acid on acute seizures and chronic behavioral comorbidities in the Theiler's murine encephalomyelitis virus mouseInternational veterinary epilepsy task force consensus proposal: outcome of therapeutic interventions in canine and feline epilepsyA Large-Scale Study Indicates Increase in the Risk of Epilepsy in Patients With Different Risk Factors, Including Rheumatoid ArthritisAnti-Inflammatory Small Molecules To Treat Seizures and Epilepsy: From Bench to BedsideGABA-ergic cell therapy for epilepsy: Advances, limitations and challenges.Neurobehavioral comorbidities of epilepsy: Role of inflammation.The vicious circle of hypometabolism in neurodegenerative diseases: Ways and mechanisms of metabolic correction.Spare the Neuron, Spoil the Network.Cryptogenic NORSE: Its distinctive clinical features and response to immunotherapy.Authors' reply to Whitlock: Perispinal etanercept for post-stroke neurological and cognitive dysfunction: scientific rationale and current evidence.Novel Targets for Developing Antiseizure and, Potentially, Antiepileptogenic Drugs.Epilepsy as a Network Disorder (2): What can we learn from other network disorders such as dementia and schizophrenia, and what are the implications for translational research?Methodological standards and interpretation of video-electroencephalography in adult control rodents. A TASK1-WG1 report of the AES/ILAE Translational Task Force of the ILAE.Chronic inhibition of brain glycolysis initiates epileptogenesis.Orthosiphon stamineus Leaf Extract Affects TNF-α and Seizures in a Zebrafish Model.Conflicting Effects of Methylglyoxal and Potential Significance of miRNAs for Seizure Treatment.
P2860
Q28595920-3361CFD5-BA4E-4BAB-9685-25B35452DDBFQ35531800-41FF1C10-2162-4714-8903-1AADFD572858Q35757818-762F01E3-79D2-4D45-AFC1-2964F0057942Q36194833-A42B93E2-1E00-45BC-9028-03F0404E3559Q37340703-FBAE1ACD-27FA-402A-B4A2-94106134F08FQ38691162-E32A21EB-0859-485B-A36B-C946F6E7BE80Q38694557-69EF068A-7311-4C36-A639-9E4F15CEAA87Q38809233-D36A106D-40F8-40F2-98D4-AE15C64BEEA9Q41031550-402C9C25-FC66-4AD4-A815-DBAF159A7BEFQ41676639-70CCB064-D0DF-4C14-B785-69647EA4F696Q43041358-A80DF13B-AD42-450C-A73B-302870544E6AQ47139898-033E6B37-2952-42A0-ADB5-A9C4CF22BCB9Q47721183-4128E43D-6115-4911-B2A0-717110207DB3Q47858408-7FFF1BE5-A93A-4E16-975A-A437D7847643Q48048374-AD06922F-DF7E-4768-B00C-DC181A183F49Q50531279-09F1895F-1359-410D-9179-5AAA8A677021Q52647791-E6E42EFD-3631-429C-9015-784BF07A73E7
P2860
Does brain inflammation mediate pathological outcomes in epilepsy?
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Does brain inflammation mediate pathological outcomes in epilepsy?
@en
type
label
Does brain inflammation mediate pathological outcomes in epilepsy?
@en
prefLabel
Does brain inflammation mediate pathological outcomes in epilepsy?
@en
P2860
P1476
Does brain inflammation mediate pathological outcomes in epilepsy?
@en
P2093
Karen S Wilcox
P2860
P304
P356
10.1007/978-94-017-8914-1_14
P407
P577
2014-01-01T00:00:00Z